ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 93 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,888,949 | -6.5% | 582,178 | +17.5% | 0.00% | 0.0% |
Q2 2023 | $4,157,874 | +37338.1% | 495,575 | -55.7% | 0.00% | -66.7% |
Q1 2023 | $11,106 | +87.7% | 1,118,431 | +31.6% | 0.01% | +100.0% |
Q4 2022 | $5,917 | -99.8% | 850,088 | +31.5% | 0.00% | +50.0% |
Q3 2022 | $3,452,000 | -30.1% | 646,394 | -47.7% | 0.00% | -33.3% |
Q2 2022 | $4,935,000 | +120.1% | 1,236,752 | +145.2% | 0.00% | +200.0% |
Q1 2022 | $2,242,000 | -69.0% | 504,462 | -72.1% | 0.00% | -66.7% |
Q4 2021 | $7,236,000 | +104.5% | 1,808,935 | +348.9% | 0.00% | +50.0% |
Q3 2021 | $3,538,000 | -23.9% | 402,943 | -1.9% | 0.00% | -33.3% |
Q2 2021 | $4,652,000 | -28.0% | 410,548 | -24.5% | 0.00% | -40.0% |
Q1 2021 | $6,461,000 | +24.1% | 543,823 | -28.4% | 0.01% | +25.0% |
Q4 2020 | $5,207,000 | +110.0% | 759,055 | +126.8% | 0.00% | +33.3% |
Q3 2020 | $2,479,000 | +4.7% | 334,614 | -41.1% | 0.00% | 0.0% |
Q2 2020 | $2,368,000 | +16.9% | 567,897 | -30.7% | 0.00% | -40.0% |
Q1 2020 | $2,025,000 | -56.3% | 819,827 | +2.7% | 0.01% | -16.7% |
Q4 2019 | $4,637,000 | +64.9% | 798,022 | +49.5% | 0.01% | +50.0% |
Q3 2019 | $2,812,000 | +95.0% | 533,632 | +122.0% | 0.00% | +100.0% |
Q2 2019 | $1,442,000 | -58.7% | 240,354 | -37.8% | 0.00% | -60.0% |
Q1 2019 | $3,489,000 | -36.1% | 386,433 | -41.3% | 0.01% | -44.4% |
Q4 2018 | $5,461,000 | -58.2% | 657,976 | -30.5% | 0.01% | -43.8% |
Q3 2018 | $13,072,000 | +126.8% | 947,225 | +30.7% | 0.02% | +100.0% |
Q2 2018 | $5,763,000 | +2.0% | 724,952 | -3.7% | 0.01% | 0.0% |
Q1 2018 | $5,649,000 | +16.1% | 753,143 | +5.2% | 0.01% | +14.3% |
Q4 2017 | $4,867,000 | +24.0% | 715,679 | +31.3% | 0.01% | +16.7% |
Q3 2017 | $3,925,000 | +740.5% | 545,085 | +442.4% | 0.01% | +500.0% |
Q2 2017 | $467,000 | -9.7% | 100,500 | -2.8% | 0.00% | 0.0% |
Q1 2017 | $517,000 | -3.4% | 103,385 | +3.4% | 0.00% | 0.0% |
Q4 2016 | $535,000 | -31.6% | 100,000 | -0.0% | 0.00% | 0.0% |
Q3 2016 | $782,000 | +5.2% | 100,003 | -23.4% | 0.00% | -50.0% |
Q2 2016 | $743,000 | +77.3% | 130,500 | +30.4% | 0.00% | +100.0% |
Q1 2016 | $419,000 | -43.8% | 100,045 | -9.1% | 0.00% | -50.0% |
Q4 2015 | $746,000 | +10.2% | 110,024 | -5.2% | 0.00% | +100.0% |
Q3 2015 | $677,000 | -26.7% | 116,100 | -2.4% | 0.00% | -50.0% |
Q2 2015 | $923,000 | – | 119,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |